Nuvation Bio (NUVB) Return on Capital Employed (2023 - 2025)
Historic Return on Capital Employed for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to 0.42%.
- Nuvation Bio's Return on Capital Employed rose 6500.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year increase of 6500.0%. This contributed to the annual value of 1.13% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Return on Capital Employed is 0.42%, which was up 6500.0% from 0.45% recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Return on Capital Employed registered a high of 0.16% during Q1 2024, and its lowest value of 1.36% during Q1 2025.
- For the 3-year period, Nuvation Bio's Return on Capital Employed averaged around 0.72%, with its median value being 0.71% (2024).
- Within the past 5 years, the most significant YoY rise in Nuvation Bio's Return on Capital Employed was 6500bps (2025), while the steepest drop was -12100bps (2025).
- Nuvation Bio's Return on Capital Employed (Quarter) stood at 0.16% in 2023, then plummeted by -630bps to 1.19% in 2024, then skyrocketed by 65bps to 0.42% in 2025.
- Its Return on Capital Employed was 0.42% in Q3 2025, compared to 0.45% in Q2 2025 and 1.36% in Q1 2025.